欢迎来到CSNpharm!产品仅用于科研!

400-920-2911 sales@csnpharm.cn

0

SARS-CoV

SARS-CoV

货号 产品名 CAS号 信息
CSN29553 SSAA09E2 883944-52-3 SSAA09E2 is a novel inhibitor of SARS-CoV replication, acting by blocking early interactions of SARS-S with the receptor for SARS-CoV, Angiotensin Converting Enzyme-2 (ACE2).
CSN17457 PLpro inhibitor 1093070-14-4 PLpro inhibitor is a potent inhibitor of papain-like protease (PLpro) with IC50 of 2.6 μM.
CSN51370 PF-00835231 870153-29-0 PF00835231 is a SARS CoV-1 3CLpro inhibitor for potential treatment of COVID-19.
CSN28746 (1R,2S,5S)-N-((S)-1-Cyano-2-((S)-2-oxopyrrolidin-3-yl)ethyl)-3-((S)-3,3-dimethyl-2-(2,2,2-trifluoroacetamido)butanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide 2628280-40-8 PF-07321332 is an orally active 3CL protease inhibitor, binding covalently and directly to the catalytic cysteine (Cys145) residue of the enzyme. It works as an anti-SARS-CoV-2 drug.
CSN44050 ((2R,3S,4R,5R)-3,4-Dihydroxy-5-((Z)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyrate 2492423-29-5 Molnupiravir is an orally bioavailable form of a highly potent ribonucleoside analog that inhibits the replication of multiple RNA viruses including SARS-CoV-2, the causative agent of COVID-19.
CSN25551 ((2R,3S,4R,5R)-3,4-Dihydroxy-5-(4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyrate   2635324-86-4 EIDD-2801 is an orally bioavailable prodrug of EIDD-1931, which has a broad-spectrum antiviral activity against 39 multiple coronaviruses, including SARS-CoV2, MERS-CoV, SARS-CoV. and related zoonotic group 2b or 2c Bat-CoVs, as well as increased potency against a coronavirus bearing resistance mutations to another nucleoside analog inhibitor.
CSN25552 1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-4-(hydroxyimino)-3,4-dihydropyrimidin-2(1H)-one 3258-02-4 EIDD-1931 has a broad-spectrum antiviral activity against multiple coronaviruses, including SARS-CoV2, MERS-CoV, SARS-CoV. and related zoonotic group 2b or 2c Bat-CoVs, as well as increased potency against a coronavirus bearing resistance mutations to another nucleoside analog inhibitor.
CSN50790 CCF0058981 2708934-53-4 CCF0058981 is a ML300-derived, non-covalent SARS-CoV‑2 3CLpro inhibitor.
CSN25478 6-Chloro-3-hydroxypyrazine-2-carboxamide 259793-90-3 6-Chloro-3-hydroxypyrazine-2-carboxamide is an intermediate for favipiravir.
CSN25477 6-Bromo-3-hydroxypyrazine-2-carboxamide 259793-88-9 6-Bromo-3-hydroxypyrazine-2-carboxamide is an intermediate for favipiravir.
CSN25476 (E)-1-(2-Hydroxy-4-methoxy-5-(3-methylbut-2-en-1-yl)phenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one 20784-60-5 4'-O-Methylbavachalcone is a chalcone isolated from Psoralea corylifolia, which can inhibit severe acute respiratory syndrome coronavirus (SARS-CoV) papain-like protease (PLpro) activity, with an IC50 of 10.1 μM
CSN60078 Bemnifosbuvir 1998705-64-8
<< PREV 1 NEXT >>
联系
我们